BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30988284)

  • 1. CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.
    Krajewska M; Dries R; Grassetti AV; Dust S; Gao Y; Huang H; Sharma B; Day DS; Kwiatkowski N; Pomaville M; Dodd O; Chipumuro E; Zhang T; Greenleaf AL; Yuan GC; Gray NS; Young RA; Geyer M; Gerber SA; George RE
    Nat Commun; 2019 Apr; 10(1):1757. PubMed ID: 30988284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK12 regulates DNA repair genes by suppressing intronic polyadenylation.
    Dubbury SJ; Boutz PL; Sharp PA
    Nature; 2018 Dec; 564(7734):141-145. PubMed ID: 30487607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing.
    Liang K; Gao X; Gilmore JM; Florens L; Washburn MP; Smith E; Shilatifard A
    Mol Cell Biol; 2015 Mar; 35(6):928-38. PubMed ID: 25561469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes.
    Chirackal Manavalan AP; Pilarova K; Kluge M; Bartholomeeusen K; Rajecky M; Oppelt J; Khirsariya P; Paruch K; Krejci L; Friedel CC; Blazek D
    EMBO Rep; 2019 Sep; 20(9):e47592. PubMed ID: 31347271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex.
    Ekumi KM; Paculova H; Lenasi T; Pospichalova V; Bösken CA; Rybarikova J; Bryja V; Geyer M; Blazek D; Barboric M
    Nucleic Acids Res; 2015 Mar; 43(5):2575-89. PubMed ID: 25712099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The U1 antisense morpholino oligonucleotide (AMO) disrupts U1 snRNP structure to promote intronic PCPA modification of pre-mRNAs.
    Feng Q; Lin Z; Deng Y; Ran Y; Yu R; Xiang AP; Ye C; Yao C
    J Biol Chem; 2023 Jul; 299(7):104854. PubMed ID: 37224962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression regulation by CDK12: a versatile kinase in cancer with functions beyond CTD phosphorylation.
    Choi SH; Kim S; Jones KA
    Exp Mol Med; 2020 May; 52(5):762-771. PubMed ID: 32451425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK12 globally stimulates RNA polymerase II transcription elongation and carboxyl-terminal domain phosphorylation.
    Tellier M; Zaborowska J; Caizzi L; Mohammad E; Velychko T; Schwalb B; Ferrer-Vicens I; Blears D; Nojima T; Cramer P; Murphy S
    Nucleic Acids Res; 2020 Aug; 48(14):7712-7727. PubMed ID: 32805052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma.
    Pitolli C; Marini A; Guerra M; Pieraccioli M; Marabitti V; Palluzzi F; Giacò L; Tamburrini G; Cecconi F; Nazio F; Sette C; Pagliarini V
    J Exp Clin Cancer Res; 2023 Aug; 42(1):214. PubMed ID: 37599362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.
    Tien JF; Mazloomian A; Cheng SG; Hughes CS; Chow CCT; Canapi LT; Oloumi A; Trigo-Gonzalez G; Bashashati A; Xu J; Chang VC; Shah SP; Aparicio S; Morin GB
    Nucleic Acids Res; 2017 Jun; 45(11):6698-6716. PubMed ID: 28334900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes.
    Blazek D; Kohoutek J; Bartholomeeusen K; Johansen E; Hulinkova P; Luo Z; Cimermancic P; Ule J; Peterlin BM
    Genes Dev; 2011 Oct; 25(20):2158-72. PubMed ID: 22012619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer.
    Quereda V; Bayle S; Vena F; Frydman SM; Monastyrskyi A; Roush WR; Duckett DR
    Cancer Cell; 2019 Nov; 36(5):545-558.e7. PubMed ID: 31668947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells.
    Zhang G; Lan B; Zhang X; Lin M; Liu Y; Chen J; Guo F
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37164450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation.
    Schmitz M; Kaltheuner IH; Anand K; Düster R; Moecking J; Monastyrskyi A; Duckett DR; Roush WR; Geyer M
    J Biol Chem; 2024 Jan; 300(1):105501. PubMed ID: 38016516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and resistance mechanism of a selective CDK12 degrader.
    Jiang B; Gao Y; Che J; Lu W; Kaltheuner IH; Dries R; Kalocsay M; Berberich MJ; Jiang J; You I; Kwiatkowski N; Riching KM; Daniels DL; Sorger PK; Geyer M; Zhang T; Gray NS
    Nat Chem Biol; 2021 Jun; 17(6):675-683. PubMed ID: 33753926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene.
    Wang B; Wang Y; Wen Y; Zhang YL; Ni WJ; Tang TT; Cao JY; Yin Q; Jiang W; Yin D; Li ZL; Lv LL; Liu BC
    Mol Ther; 2022 Oct; 30(10):3300-3312. PubMed ID: 35581939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and therapeutic potential of CDK12 in human cancers.
    Chilà R; Guffanti F; Damia G
    Cancer Treat Rev; 2016 Nov; 50():83-88. PubMed ID: 27662623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAPTURE of the Human U2 snRNA Genes Expands the Repertoire of Associated Factors.
    Guiro J; Fagbemi M; Tellier M; Zaborowska J; Barker S; Fournier M; Murphy S
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Complex of U1 snRNP with Cleavage and Polyadenylation Factors Controls Telescripting, Regulating mRNA Transcription in Human Cells.
    So BR; Di C; Cai Z; Venters CC; Guo J; Oh JM; Arai C; Dreyfuss G
    Mol Cell; 2019 Nov; 76(4):590-599.e4. PubMed ID: 31522989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.
    Cheng SW; Kuzyk MA; Moradian A; Ichu TA; Chang VC; Tien JF; Vollett SE; Griffith M; Marra MA; Morin GB
    Mol Cell Biol; 2012 Nov; 32(22):4691-704. PubMed ID: 22988298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.